spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Matrix Laboratories 

 HSMN NewsFeed - 6 Aug 2012
Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 23 Feb 2012
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
Biopharmaceuticals Generics HIV/AIDS FDA
 HSMN NewsFeed - 15 Feb 2012
Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2011
Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2011
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
Biopharmaceuticals Generics Gastroenterology FDA
 HSMN NewsFeed - 14 Jul 2010
Mylan Receives Approval for Nabumetone Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2010
Mylan Receives Approval for Generic Version of Neurontin(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Biopharmaceuticals Generics HIV/AIDS FDA
 HSMN NewsFeed - 22 Dec 2009
Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories' New Drug Application (NDA) for Efavirenz Tablets
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 16 Sep 2009
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 18 Aug 2009
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2009
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 20 Mar 2009
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Mar 2009
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Biopharmaceuticals Generics FDA HIV/AIDS
 HSMN NewsFeed - 30 Dec 2008
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
Biopharmaceuticals Generics FDA HIV/AIDS
 HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 27 Feb 2008
Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2008
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2008
Mylan Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2008
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2008
Mylan Restores Availability of Generic Levothyroxine in Florida
Biopharmaceuticals Generics
 HSMN NewsFeed - 1 Feb 2008
Mylan Announces Final FDA Approval for Granisetron Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Dec 2007
Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Dec 2007
Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 4 Dec 2007
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Biopharmaceuticals HIV/AIDS Generics FDA
 HSMN NewsFeed - 2 Dec 2007
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Nov 2007
Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2007
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2007
Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD
Biopharmaceuticals
 HSMN NewsFeed - 24 Oct 2007
Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2007
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Oct 2007
Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2007
Mylan Completes Acquisition of Generics Business of Merck KGaA
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of John Montgomery as President, Asia Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Mylan Announces Management of Specialty Business, Dey L.P.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Heather Bresch as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Harry A. Korman as President, North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2007
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2007
Mylan Announces Tentative FDA Approval for Topiramate Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Sep 2007
Mylan Announces Final FDA Approval for Carvedilol Tablets
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jun 2007
Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Jun 2007
Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 May 2007
Mylan Announces Final FDA Approval for Azithromycin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 May 2007
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2007
Mylan Announces Final FDA Approval for Fluoxetine Capsules USP, 40 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 May 2007
Mylan Laboratories to Acquire Generics Business of Merck KGaA
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2007
Mylan Announces Tentative FDA Approval for Letrozole Tablets, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 May 2007
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Biopharmaceuticals Generics Endocrinology FDA
 HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Feb 2007
Mylan Announces Final FDA Approval for Sertraline Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Jan 2007
Mylan Laboratories Announces Strategic Global Reorganization to Maximize Growth Opportunities and Leverage Efficiencies Provided by New Global Platform
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2007
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
Biopharmaceuticals Drug Delivery Generics FDA
 HSMN NewsFeed - 31 Jan 2007
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 31 Jan 2007
The Practice of Authorized Generics During the 180-Day Exclusivity Period May Be Nearing its End With the Introduction of S. 438 - 'The Fair Prescription Drug Competition Act of 2007'
Biopharmaceuticals Generics
 HSMN NewsFeed - 30 Jan 2007
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Dec 2006
Mylan Announces the Hiring of David F. Mulder to the Position of Senior Vice President, Corporate and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Aug 2006
Mylan Laboratories to Acquire Up to 71.5% Controlling Interest in Matrix Laboratories
Biopharmaceuticals Mergers & Acquisitions
Return to NewsFeed  
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.